Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fecal microbiota transplant (Maimónides Institute of Biomedical Research of Córdoba)
- Development stage
- Unknown
- Lead developer
- Maimónides Institute of Biomedical Research of Córdoba
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Fecal microbiota transplant (FMT) is a live biotherapeutic product being investigated by the Maimónides Biomedical Research Institute of Córdoba for the selective intestinal decolonization of patients colonized by carbapenemase-producing Klebsiella pneumoniae (Kp-KPC). It is being studied in a Phase 2, randomized, double-blind, placebo-controlled trial called KAPEDIS (NCT04760665). The therapy involves administering encapsulated, lyophilized fecal microbiota from healthy donors to restore a healthy gut microbiome. The intended mechanism is to leverage competitive exclusion and other ecological interactions to eradicate Kp-KPC, thereby reducing the patient's risk of developing subsequent infections, which are often associated with high mortality rates.
- Other names
- FMT
Beyond the preview
Go deeper on fecal microbiota transplant (Maimónides Institute of Biomedical Research of Córdoba).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fecal microbiota transplant (Maimónides Institute of Biomedical Research of Córdoba).